(Q85084811)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21993925%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

title

Prospective biopsy-controlled evaluation of cell death biomarkers for prediction of liver fibrosis and nonalcoholic steatohepatitis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21993925%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

1 reference

1 reference

Diana Joka

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21993925%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Kristin Wahl

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21993925%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Sarah Moeller

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21993925%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Jerome Schlue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21993925%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Bernhard Vaske

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21993925%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Matthias J Bahr

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21993925%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Michael P Manns

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21993925%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Klaus Schulze-Osthoff

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21993925%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Heike Bantel

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21993925%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

publication date

29 November 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21993925%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21993925%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

volume

55

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21993925%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21993925%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

page(s)

455-464

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21993925%20AND%20SRC:MED&resulttype=core&format=json

Nonalcoholic fatty liver disease

14 February 2020

cites work

1 reference

7 January 2021

Long-term follow-up of patients with NAFLD and elevated liver enzymes

1 reference

7 January 2021

1 reference

7 January 2021

The NAFLD fibrosis score: A noninvasive system that identifies liver fibrosis in patients with NAFLD

1 reference

7 January 2021

Noninvasive markers of fibrosis in nonalcoholic fatty liver disease: Validating the European Liver Fibrosis Panel and exploring simple markers

1 reference

7 January 2021

Diagnosis of nonalcoholic fatty liver disease: invasive versus noninvasive

1 reference

7 January 2021

Measurement of serum hyaluronic acid in patients with chronic hepatitis C and its relationship to liver histology. Consensus Interferon Study Group

1 reference

7 January 2021

Targeting liver fibrosis: strategies for development and validation of antifibrotic therapies.

1 reference

7 January 2021

Serum markers detect the presence of liver fibrosis: a cohort study.

1 reference

7 January 2021

Non invasive fibrosis biomarkers reduce but not substitute the need for liver biopsy

1 reference

7 January 2021

Cellular and molecular mechanisms of liver injury

1 reference

7 January 2021

Apoptosis in hepatitis C virus infection

1 reference

7 January 2021

Many cuts to ruin: a comprehensive update of caspase substrates

1 reference

7 January 2021

Immunocytochemical detection and mapping of a cytokeratin 18 neo-epitope exposed during early apoptosis

1 reference

7 January 2021

In situ monitoring of caspase activation in hepatobiliary diseases

1 reference

7 January 2021

Detection of elevated caspase activation and early apoptosis in liver diseases

1 reference

7 January 2021

Detection of apoptotic caspase activation in sera from patients with chronic HCV infection is associated with fibrotic liver injury

1 reference

7 January 2021

The extent of liver steatosis in chronic hepatitis C virus infection is mirrored by caspase activity in serum

1 reference

7 January 2021

Apoptotic cytokeratin 18 neoepitopes in serum of patients with chronic hepatitis C.

1 reference

7 January 2021

Caspase activation is associated with spontaneous recovery from acute liver failure

1 reference

7 January 2021

Caspase activation is required for antiviral treatment response in chronic hepatitis C virus infection

1 reference

7 January 2021

In vivo assessment of liver cell apoptosis as a novel biomarker of disease severity in nonalcoholic fatty liver disease

1 reference

7 January 2021

Soluble forms of extracellular cytokeratin 18 may differentiate simple steatosis from nonalcoholic steatohepatitis

1 reference

7 January 2021

Cytokeratin-18 fragment levels as noninvasive biomarkers for nonalcoholic steatohepatitis: a multicenter validation study

1 reference

7 January 2021

Molecular mechanisms of necroptosis: an ordered cellular explosion

1 reference

7 January 2021

Cell death and fibrogenesis

1 reference

7 January 2021

Histological grading and staging of chronic hepatitis

1 reference

7 January 2021

Design and validation of a histological scoring system for nonalcoholic fatty liver disease

1 reference

7 January 2021

Transient elastography: a new noninvasive method for assessment of hepatic fibrosis.

1 reference

7 January 2021

Diagnostic and prognostic role of plasma levels of two forms of cytokeratin 18 in patients with non-small-cell lung cancer

1 reference

7 January 2021

Prevalence and factors associated with failure of liver stiffness measurement using FibroScan in a prospective study of 2114 examinations

1 reference

7 January 2021

Non-invasive evaluation of liver fibrosis using transient elastography

1 reference

7 January 2021

The Caspase Inhibitor IDN-6556 Attenuates Hepatic Injury and Fibrosis in the Bile Duct Ligated Mouse

1 reference

7 January 2021

Effect of antiviral therapy on circulating cytokeratin-18 fragments in patients with chronic hepatitis C.

1 reference

7 January 2021

Serum markers of hepatocyte death and apoptosis are non invasive biomarkers of severe fibrosis in patients with alcoholic liver disease

1 reference

7 January 2021

Apoptosis markers related to pathogenesis of pediatric chronic hepatitis C virus infection: M30 mirrors the severity of steatosis

1 reference

7 January 2021

Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase levels: a role for insulin resistance and diabetes

1 reference

7 January 2021

Clinical and histologic spectrum of nonalcoholic fatty liver disease associated with normal ALT values

1 reference

7 January 2021

Noninvasive assessment of liver disease severity with liver fat score and CK-18 in NAFLD: Prognostic value of liver fat equation goes beyond hepatic fat estimation.

1 reference

7 January 2021

Cytokeratin 18 fragment levels as a noninvasive biomarker for nonalcoholic steatohepatitis in bariatric surgery patients

1 reference

7 January 2021

Serum levels of CK18 M30 and leptin are useful predictors of steatohepatitis and fibrosis in paediatric NAFLD

1 reference

7 January 2021

Disease progression of non-alcoholic fatty liver disease: a prospective study with paired liver biopsies at 3 years

1 reference

7 January 2021

A new composite model including metabolic syndrome, alanine aminotransferase and cytokeratin-18 for the diagnosis of non-alcoholic steatohepatitis in morbidly obese patients.

1 reference

7 January 2021

A novel diagnostic biomarker panel for obesity-related nonalcoholic steatohepatitis (NASH).

1 reference

7 January 2021

Identifiers

DOI

10.1002/HEP.24734

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21993925%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

1 reference